336 related articles for article (PubMed ID: 23796211)
1. Contrast-enhanced MR enterography as a stand-alone tool to evaluate Crohn's disease in a paediatric population.
Spieler B; Hindman N; Levy J; Zabrieski K; Sahlein D; Seuss C; Kim S
Clin Radiol; 2013 Oct; 68(10):1024-30. PubMed ID: 23796211
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic evaluation of chronic inflammatory intestinal diseases in children and adolescents: MRI with true-FISP as new gold standard?].
Hohl C; Haage P; Krombach GA; Schmidt T; Ahaus M; Günther RW; Staatz G
Rofo; 2005 Jun; 177(6):856-63. PubMed ID: 15902636
[TBL] [Abstract][Full Text] [Related]
3. Impact of gadolinium-based contrast agent in the assessment of Crohn's disease activity: Is contrast agent injection necessary?
Quaia E; Sozzi M; Gennari AG; Pontello M; Angileri R; Cova MA
J Magn Reson Imaging; 2016 Mar; 43(3):688-97. PubMed ID: 26250897
[TBL] [Abstract][Full Text] [Related]
4. Biochemical markers and MR imaging findings as predictors of crohn disease activity in patients scanned by contrast-enhanced MR enterography.
Quaia E; Cabibbo B; Sozzi M; Gennari AG; Pontello M; Degrassi F; Cova MA
Acad Radiol; 2014 Oct; 21(10):1225-32. PubMed ID: 24998692
[TBL] [Abstract][Full Text] [Related]
5. MR of the small bowel with a biphasic oral contrast agent (polyethylene glycol): technical aspects and findings in patients affected by Crohn's disease.
Laghi A; Paolantonio P; Iafrate F; Borrelli O; Dito L; Tomei E; Cucchiara S; Passariello R
Radiol Med; 2003; 106(1-2):18-27. PubMed ID: 12951547
[TBL] [Abstract][Full Text] [Related]
6. [MR enterography sequence evaluation for patients with Crohn's disease].
Schleder S; Dendl LM; Pawlik M; Friedrich C; Ott C; Agha A; Wiggermann P; Stroszczynski C; Schreyer AG
Rofo; 2013 May; 185(5):440-5. PubMed ID: 23440646
[TBL] [Abstract][Full Text] [Related]
7. MR imaging evaluation of the activity of Crohn's disease.
Koh DM; Miao Y; Chinn RJ; Amin Z; Zeegen R; Westaby D; Healy JC
AJR Am J Roentgenol; 2001 Dec; 177(6):1325-32. PubMed ID: 11717076
[TBL] [Abstract][Full Text] [Related]
8. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent.
Maccioni F; Bruni A; Viscido A; Colaiacomo MC; Cocco A; Montesani C; Caprilli R; Marini M
Radiology; 2006 Feb; 238(2):517-30. PubMed ID: 16371574
[TBL] [Abstract][Full Text] [Related]
9. Performance of Surveillance MR Enterography (MRE) in Asymptomatic Children and Adolescents With Crohn's Disease.
Chu KF; Moran CJ; Wu K; Kaplan JL; Savarino JR; Board T; Israel EJ; Winter HS; Gee MS
J Magn Reson Imaging; 2019 Dec; 50(6):1955-1963. PubMed ID: 31145502
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.
Hecht EM; Holland AE; Israel GM; Hahn WY; Kim DC; West AB; Babb JS; Taouli B; Lee VS; Krinsky GA
Radiology; 2006 May; 239(2):438-47. PubMed ID: 16641353
[TBL] [Abstract][Full Text] [Related]
11. MRI of soft-tissue tumors: fast STIR sequence as substitute for T1-weighted fat-suppressed contrast-enhanced spin-echo sequence.
Tokuda O; Harada Y; Matsunaga N
AJR Am J Roentgenol; 2009 Dec; 193(6):1607-14. PubMed ID: 19933655
[TBL] [Abstract][Full Text] [Related]
12. Can a multiphasic contrast-enhanced three-dimensional fast spoiled gradient-recalled echo sequence be sufficient for liver MR imaging?
Coulam CH; Chan FP; Li KC
AJR Am J Roentgenol; 2002 Feb; 178(2):335-41. PubMed ID: 11804888
[TBL] [Abstract][Full Text] [Related]
13. Role of spectral presaturation attenuated inversion-recovery fat-suppressed T2-weighted MR imaging in active inflammatory bowel disease.
Udayasankar UK; Martin D; Lauenstein T; Rutherford R; Galloway J; Tudorascu D; Sitaraman SV
J Magn Reson Imaging; 2008 Nov; 28(5):1133-40. PubMed ID: 18972354
[TBL] [Abstract][Full Text] [Related]
14. Hoffa's Fat Pad: Evaluation on Unenhanced MR Images as a Measure of Patellofemoral Synovitis in Osteoarthritis.
Roemer FW; Guermazi A; Zhang Y; Yang M; Hunter DJ; Crema MD; Bohndorf K
AJR Am J Roentgenol; 2009 Jun; 192(6):1696-700. PubMed ID: 19457837
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
Oto A; Fan X; Mustafi D; Jansen SA; Karczmar GS; Rubin DT; Kayhan A
Acad Radiol; 2009 Oct; 16(10):1223-30. PubMed ID: 19524458
[TBL] [Abstract][Full Text] [Related]
16. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
17. Preoperative evaluation of small bowel complications in Crohn's disease: comparison of diffusion-weighted and contrast-enhanced MR imaging.
Barat M; Hoeffel C; Bouquot M; Jannot AS; Dautry R; Boudiaf M; Pautrat K; Kaci R; Camus M; Eveno C; Pocard M; Soyer P; Dohan A
Eur Radiol; 2019 Apr; 29(4):2034-2044. PubMed ID: 30302591
[TBL] [Abstract][Full Text] [Related]
18. Imaging for Crohn disease: use of 3-T MRI in a paediatric setting.
Dagia C; Ditchfield M; Kean M; Catto-Smith T
J Med Imaging Radiat Oncol; 2008 Oct; 52(5):480-8. PubMed ID: 19032394
[TBL] [Abstract][Full Text] [Related]
19. MR imaging of head and neck tumors: comparison of T1-weighted contrast-enhanced fat-suppressed images with conventional T2-weighted and fast spin-echo T2-weighted images.
Ross MR; Schomer DF; Chappell P; Enzmann DR
AJR Am J Roentgenol; 1994 Jul; 163(1):173-8. PubMed ID: 8010208
[TBL] [Abstract][Full Text] [Related]
20. Measurement of MRI enhancement kinetics for evaluation of inflammatory activity in Crohn's disease.
Röttgen R; Grandke T; Grieser C; Lehmkuhl L; Hamm B; Lüdemann L
Clin Imaging; 2010; 34(1):29-35. PubMed ID: 20122516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
